Stoke Therapeutics, Inc. (STOK)
28.51
-0.21
(-0.73%)
USD |
NASDAQ |
Jan 21, 10:39
Stoke Therapeutics Market Cap: 1.628B for Jan. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 25.00B |
| Insmed, Inc. | 34.11B |
| Aldeyra Therapeutics, Inc. | 288.78M |
| Mirum Pharmaceuticals, Inc. | 4.705B |
| Moderna, Inc. | 18.05B |
Market Cap Related Metrics
| PE Ratio | 43.20 |
| PS Ratio | 8.090 |
| Price to Book Value | 5.285 |
| Price to Free Cash Flow | 31.77 |
| Price | 28.51 |
| Earnings Yield | 2.31% |
| Operating PE Ratio | 61.17 |
| Normalized PE Ratio | 43.20 |